Trials / Conditions / Follicular Lymphoma, Grade 2
Follicular Lymphoma, Grade 2
4 registered clinical trials studyying Follicular Lymphoma, Grade 2 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Watch and Wait or Worry and Wait in Indolent Lymphoma NCT07173790 | Seoul National University Hospital | — |
| Terminated | Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma NCT03919175 | Massachusetts General Hospital | Phase 2 |
| Terminated | Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy NCT02966730 | Memorial Sloan Kettering Cancer Center | EARLY_Phase 1 |
| Completed | "MIRO" Molecularly Oriented Immuno-radio-therapy NCT02710643 | Fondazione Italiana Linfomi - ETS | Phase 2 |